disilver-oxide and Varicose-Ulcer

disilver-oxide has been researched along with Varicose-Ulcer* in 2 studies

Trials

2 trial(s) available for disilver-oxide and Varicose-Ulcer

ArticleYear
Silver oxide ointment wound dressing in venous ulcerations: home, self-management.
    Panminerva medica, 2011, Volume: 53, Issue:3 Suppl 1

    Venous ulcers are a common, chronic medical and social problem. These ulcers are difficult to heal in most patients with sustained venous hypertension. This pilot product evaluation registry study has evaluated the efficacy and safety of an antimicrobial silver oxide wound dressing ointment ("Silver Oxide Ointment") as part of the treatment of 'difficult' venous ulcerations.. The study was conducted measuring the variations in the area of the ulceration and microcirculatory parameters.. After four weeks, treatment with the Silver Oxide Ointment proved more effective than the 'best management' used in controls. Transcutaneous PO2 was increased (improved); Laser Doppler skin flux and transcutaneous PCO2 were improved (decreased). Also in the silver oxide group a significantly higher number of venous ulcers were completely healed at four weeks. The silver oxide ointment improved both the microcirculation and the healing rate of their ulcers. No significant tolerability problems were observed.. In difficult venous ulcerations, local treatment with this Silver Oxide Ointment, as one component of the total wound dressing, improved microcirculation measurements and healing rate. Most of the treatments were done at home by the patients or by their tutors. This study indicates the important role of this type of treatment and indicates the need to plan larger and more prolonged studies.

    Topics: Adult; Bandages; Female; Home Care Services; Humans; Male; Microcirculation; Middle Aged; Ointments; Oxides; Pilot Projects; Registries; Self Administration; Silver Compounds; Stockings, Compression; Treatment Outcome; Varicose Ulcer; Wound Healing

2011
Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment.
    Panminerva medica, 2010, Volume: 52, Issue:2 Suppl 1

    In addition to contemporary compression therapy, one of the therapeutic approaches is the use of a topical wound care agent. The goal of this pilot registry study is to evaluate the efficacy and safety of a uniquely designed ointment containing multivalent silver oxide (Ag4O4) in the healing of difficult diabetic or venous ulcerations.. Patients who had ulcers resulting from chronic venous insufficiency or diabetes participated in this open-label, randomized registry study. All patients were evaluated by measuring both the area of the ulceration and microcirculatory parameters. 148 patients were included in the study and categorized into two main groups: venous ulcers and diabetic ulcers. Each main group was then randomized into two sub-groups: topical treatment with silver oxide ointment and the control group (standard cleaning and compression management methods, without silver ointment). All patients were treated with accepted cleaning and compression management. RESULTS. In subjects with venous ulcers: After 4 weeks, the silver treatment was more effective than the control group treatment: Skin PO2 was increased 2.1 times more than the control group (17.4% to 8.2%) and skin flux (RF) was improved 1.6 times more than the control group (-38.7% to -24.2%). The total surface area of the ulcer was significantly reduced in the silver treatment group by 1.9 times the control group (-88.7% to -46.9%). In addition, in the silver treatment group we observed complete closure of the ulceration in 42% of subjects compared to 22% in the control group (P=<0.05). In subjects with diabetic ulcers: after 4 weeks, the silver treatment was more effective than the control group treatment: Skin PO2 increased 2.6 times more than the control group (23.3% to 9.1%) and skin flux (RF) was significantly improved 4.3 times more than the control group(-26.7% to -6.2%). The total surface area of the ulcer was significantly reduced in the silver treatment group by 3.7 times the control group (-89.0% to -23.9%). In addition, in the silver treatment group we observed complete closure of the ulceration in 39% of subjects compared to 16% in the control group (P

    Topics: Administration, Topical; Adult; Diabetes Complications; Diabetic Angiopathies; Female; Humans; Male; Microcirculation; Middle Aged; Ointments; Oxides; Pilot Projects; Silver Compounds; Skin; Treatment Outcome; Varicose Ulcer; Wound Healing

2010